Results
1 -
10 of
23
(Click
here to explore results)
- Anti-fibrotic Drug Discovery, CHAPTER 9 BH3 Mimetic Drugs for Anti-fibrotic Therapy. David Lagares
, 2020
, Pages 235-258
- Inhibitors of Protein–Protein Interactions: Small Molecules, Peptides and Macrocycles, Chapter 4 Identifying and Developing Small Molecule Inhibitors of Protein–Protein Interactions. Rhian S. Holvey, Samuel E. Dalton, Tom D. Heightman, David C. Rees
, 2021
, Pages 111-159
- Peptide-based Drug Discovery: Challenges and New Therapeutics, CHAPTER 11 Development of Peptide-Based Diagnostic and Therapeutic Agents in Oncology. Kamala Kesavan
, 2017
, Pages 326-363
- Protein–Protein Interaction Regulators, CHAPTER 8 Discovery and Development of Mcl-1 Inhibitors as Anti-cancer Therapeutics: Hit to Clinical Candidate Optimization. Karson J. Kump, Zaneta Nikolovska-Coleska
, 2021
, Pages 171-208
- The Medicinal Chemist's Guide to Solving ADMET Challenges, Subject Index
, 2021
, Pages 493-517
- NMR Spectroscopy for Probing Functional Dynamics at Biological Interfaces, Chapter 15 Structure- and Dynamics-guided Drug Development Using NMR and its Application to Diverse Pharmaceutical Modalities. Koh Takeuchi
, 2022
, Pages 411-448
- Small-molecule Transcription Factor Inhibitors in Oncology, Chapter 5 Small Molecule Inhibitors of NF-κB and Their Therapeutic Potential in Leukaemia. Chris Pepper, Chris Fegan
, 2019
, Pages 125-146
- Fragment-Based Drug Discovery, CHAPTER 6 Fragment-Based Lead Discovery Applied to Protein–Protein Interactions. Roderick E. Hubbard
, 2015
, Pages 126-152
- Anti-fibrotic Drug Discovery, Subject Index
, 2020
, Pages 340-347
- The Discovery and Utility of Chemical Probes in Target Discovery, CHAPTER 10 Assays to Characterize the Cellular Pharmacology of a Chemical Probe. Jakub Stefaniak, Sébastien R. G. Galan, Kilian V. M. Huber
, 2021
, Pages 247-275